arrow
R

Richard Turkington

Centre for Public Health
H指数:42
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ambient PM2.5 exposure and pancreatic cancer risk in a Northern Ireland population-based case-control study

环境PM2.5暴露与北爱尔兰人群胰腺癌风险的基于人群的病例对照研究

2026-10-060
OA
Research Priorities for Cancers of the Oesophagus and Stomach: Recommendations from a United Kingdom & Ireland Patient and Healthcare Professional Partnership Exercise

食管和胃癌的研究优先事项:来自英国与爱尔兰患者和医疗保健专业人士合作练习的建议

2025-12-010
PRE
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial
2024-11-010
PRE
A single arm phase II trial of trastuzumab deruxtecan in patients with gastro-oesophageal adenocarcinoma cancer who are ctDNA and HER2 positive: DECIPHER (TRIALS IN PROGRESS)

在ctDNA和HER2阳性的胃食管腺癌患者中进行曲妥珠单抗deruxtecan的单臂II期试验: 破译 (正在进行的试验)

2024-06-010
PRE
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
2024-05-011
OAAI
A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium

食道癌临床和分子分层联盟的十年

2023-12-190
PRE
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
2023-11-0159
OAAI
Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma

影响食管腺癌演变的突变特征动力学

2023-07-159
OAAI
The prognostic effect of pathological lymph node regression after neoadjuvant chemotherapy for oesophageal adenocarcinoma - a multicentre study
2022-12-070
OA
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy
2022-05-018
OAAI